Myo-inositol doesn’t lower risk of pregnancy complications in PCOS patients: studyWhen compared to a placebo, myo-inositol supplements did not reduce incidences of pregnancy complications in people with PCOS. Drug News—October 2025A review of new launches, new indications, new dosage forms and Health Canada advisories. New topical JAK inhibitor available for treating chronic hand eczema Anzupgo (delgocitinib topical cream) is indicated for the treatment of moderate to severe chronic hand eczema in adults. NEW PRODUCT: Hepcludex for hepatitis D Get the info you need on this new product, part of our drug news roundup for October. Obesity: Why do so many patients abandon GLP-1 agonists? Despite the hype surrounding GLP-1 receptor agonists, a significant proportion of patients discontinue treatment after a few months, reducing the chances of long-term benefits. Pharmacological treatment of COPD There are evidence-based ways to make a difference for patients. NEW PRODUCT: Alyftrek for cystic fibrosis Get the info you need on this new product, part of our drug news roundup for October. How doctors can help patients get ahead of extreme nausea and vomiting in pregnancy Up to 31% of patients with Hyperemesis Gravidarum stop meds because of side effects. GLP-1 inhibitors may protect against brain degeneration Study participants who were treated with the GLP-1 inhibitor had a lower risk of dementia, ischemic stroke and all-cause mortality. October drug roundup: two new dosage forms Get the info you need on these new dosage forms, part of our drug news roundup for October. First Previous 3 4 5 6 7 Next Last
